LDHA and acute myeloid leukemia: Key risk factors for CNS involvement in AML include complex karyotypes, AML relapse, FAB M5 classification, high LDH levels (Lactate Dehydrogenase A, LDHA), the presence of other extramedullary AML manifestations, and FLT3-ITD mutations [221].